Skip to content

Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings

Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings: a Prospective Cohort Study in South Sudan and DRC

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04568499
Enrollment
592
Registered
2020-09-29
Start date
2020-11-27
Completion date
2021-09-30
Last updated
2021-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

COVID-19 risk factors, COVID-19 outcomes, Africa, South Sudan, Democratic Republic of the Congo, Humanitarian

Brief summary

This study will characterize risk factors for poor COVID-19 outcomes (hospitalization, death) and clinical progression of hospitalized COVID-19 patients in South Sudan and Eastern Democratic Republic of the Congo.

Detailed description

A prospective cohort design will be used to follow suspected, probable, and confirmed COVID-19 cases presenting for care at International Medical Corp \[supported\] health facilities in Juba, South Sudan and the Kivus in Eastern Democratic Republic of the Congo (DRC). This research seeks to assess risk factors for poor outcomes and characterize clinical disease progression of COVID-19 cases in resource-poor humanitarian contexts in Africa. Specifically, this study aims to characterize risk factors for poor COVID-19 outcomes, including both co-morbidities with evidence from high income settings, as well as prevalent conditions in humanitarian settings (e.g., acute malnutrition, malaria, HIV) for which data is not yet available. This research also aims to determine how the progression of confirmed COVID-19 cases in resource-poor African settings may differ from other settings where data are available.

Interventions

None listed

Sponsors

International Medical Corps
CollaboratorUNKNOWN
Centers for Disease Control and Prevention
CollaboratorFED
Johns Hopkins Bloomberg School of Public Health
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Suspected, probable, and confirmed COVID-19 cases presenting for care at participating health facilities (either by walk-in, referral or transfer) or identified by mobile contact tracing teams.

Exclusion criteria

* Individuals unable or unwilling to give informed consent (e.g., due to mental impairment)

Design outcomes

Primary

MeasureTime frameDescription
Hospitalizationpatients will be followed until asymptomatic or deceased (an average of approximately 1 month)Hospitalization due to COVID-19 (proportion of participants hospitalized and risk factors for hospitalization)
Mortalitypatients will be followed until asymptomatic or deceased (an average of approximately 1 month)Death due to COVID-19 (proportion of participants deceased and risk factors for death)

Countries

Democratic Republic of the Congo, South Sudan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026